Transcript Title

mHealth
EPSA Annual Reception 2014
Edwin Maarseveen, DG SANCO, European Commission
"Mercom Capital Group, a consulting
firm, reckons that of the $2.2 billion
venture capitalists put into healthcare startups last year, $564m went
to m-health businesses."
The Economist, 2014
mHealth – Risks
‼
‼
‼
‼
‼
‼
‼
Privacy issues
Health inequalities
Disruptive economic effects
Legal uncertainty
Quality assurance
Cross-border
……
mHealth – potential
+ Efficiency, sustainability, saving costs
+ Easier Access
+ Better Information
+ Evidence-based and personalised treatment
+ Economic possibility industry
+ ……
mHealth – part of HC transition
Patient involvement/empowerment
More support from data and transparency
More personalised
Health care not a 'stand-alone' sector
Less linked to property
PURPOSE
OF THE
GREEN PAPER
ON M-HEALTH
• The Green Paper on mHealth will launch a
debate among stakeholders on what should be
done at EU level to release the potential of
mHealth in Europe.
• It will be accompanied by a SWD explaining the
legal framework applicable to health and
wellbeing apps
→Due to be published during Q1 2014
mHealth – personal statement
1. Mobile will develop fast: HC should use it
2. mHealth similar to health systems transition
3. Biggest thing about mHealth = Big Data